Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Blueprint Medicines Corp (BPMC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Blueprint Medicines Corp's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
105.00 +2.61    +2.55%
10:37:13 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 61,359
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 102.56 - 105.60
Blueprint Medicines Corp 105.00 +2.61 +2.55%

BPMC Balance Sheet

 
Featured here, the Balance Sheet for Blueprint Medicines Corp, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 776.6 808.39 808.17 811.34
Cash and Short Term Investments 647.9 710.64 712.98 722.63
Cash - - - -
Cash & Equivalents 113.33 71.29 55.97 75.53
Short Term Investments 534.58 639.36 657.01 647.11
Total Receivables, Net 60.05 43.18 41.25 38.27
Accounts Receivables - Trade, Net 60.05 43.18 41.25 38.27
Total Inventory 30.94 21.22 16.46 17.02
Prepaid Expenses 37.71 33.35 37.48 33.42
Other Current Assets, Total - - - -
Total Assets 1038.48 1049.25 1105.3 1106.44
Property/Plant/Equipment, Total - Net 113.17 115.65 115.84 114.49
Property/Plant/Equipment, Total - Gross - 154.14 - -
Accumulated Depreciation, Total - -38.49 - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments 115.49 84.32 142.03 141.72
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 33.21 40.89 39.26 38.9
Other Assets, Total 505.47 617.4 632.22 625.86
Total Current Liabilities 206.6 214.92 197.38 169.03
Accounts Payable 4.93 4.71 6.96 6.98
Payable/Accrued - - - -
Accrued Expenses 86.51 110.53 94.34 87.61
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 87.15 81.41 76.98 57.56
Other Current liabilities, Total 28.01 18.28 19.11 16.88
Total Liabilities 727.79 918.64 902.69 795.32
Total Long Term Debt 432.3 610.96 613.17 531.08
Long Term Debt 432.3 610.96 613.17 531.08
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total -149.92 -144.26 -294.91 -193.87
Total Equity 310.69 130.61 202.61 311.13
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.063 0.061 0.061 0.061
Additional Paid-In Capital 2565.28 2473.98 2434.26 2410.6
Retained Earnings (Accumulated Deficit) -2250.81 -2339.94 -2229.02 -2095.31
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -3.85 -3.5 -2.68 -4.22
Total Liabilities & Shareholders' Equity 1038.48 1049.25 1105.3 1106.44
Total Common Shares Outstanding 62.59 61.15 60.74 60.64
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BPMC Comments

Write your thoughts about Blueprint Medicines Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alejandro Pe
Alejandro Pe Jun 16, 2021 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There we go. Not big profit but a profit in a red day for the industry.
Alejandro Pe
Alejandro Pe Jun 15, 2021 10:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone loading for tomorrow? I am.
Ronen xyz
Ronen xyz Jun 12, 2021 11:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bought on the dip, fda going to spike the price
Ronen xyz
Ronen xyz Jun 12, 2021 11:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
where is the spike ?
Alejandro Pe
Alejandro Pe Jun 10, 2021 5:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00247-3/fulltext
Alejandro Pe
Alejandro Pe Jun 09, 2021 9:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
PDUFA date coming up
Juan Carlos Gutierrez
Juan Carlos Gutierrez Jul 14, 2020 3:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the average target price is 93.5 and the high target price is 122 why is nobody buying?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email